CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus YÖKSİS DOI Eşleşti SJR Q2

Arachidonic Acid Metabolites in Neurologic Disorders

CNS and Neurological Disorders Drug Targets · Şubat 2022

Özet
Background and Objective: Arachidonic acid (ARA) is essential for the fluidity, selective permeability, and flexibility of the cell membrane. It is an important factor for the function of all cells, particularly in the nervous system, immune system, and vascular endothelium. ARA is the second most common polyunsaturated fatty acid in the phospholipids of the nerve cell membrane after docosahexaenoic acid. ARA metabolites have many kinds of physiologic roles. The major action of ARA metabolites is the promotion of the acute inflammatory response, mediated by the production of pro-inflammatory mediators such as PGE2 and PGI2, followed by the formation of lipid mediators, which have pro-resolving effects. Another important action of ARA derivatives, especially COX, is the regulation of vascular reactivity through PGs and TXA2. There is significant involvement of ARA metabolites in neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and neuropsychiatric disorders. ARA derivatives also make an important contribution to acute stroke, global ischemia, subarachnoid hemorrhage, and anticoagulation-related hemorrhagic transformation. Conclusion: In this review, we have discussed experimental and human study results of neurologic disorders related to ARA and its metabolites in line with treatment options.
45 atıf Şubat 2022 DOI
YÖKSİS DOI Eşleşmesi Bulundu

Bu Scopus makalesi YÖKSİS veritabanında da kayıtlı. Aşağıda YÖKSİS verilerini görebilirsiniz.

YÖKSİS Kayıtları
Arachidonic Acid Metabolites in Neurologic Disorders
CNS & Neurological Disorders - Drug Targets · 2022 SCI-Expanded
Prof. Dr. ŞEREFNUR ÖZTÜRK →
Arachidonic Acid Metabolites in Neurologic Dis
CNS & Neurological Disorders - Drug Targets · 2022 SCI
Prof. Dr. HÜLAGU BARIŞKANER →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 3 kaydı bulundu.
Arachidonic Acid Metabolites in Neurologic Disorders
2022 ISSN: 1871-5273 SCI-Expanded Q2
Prof. Dr. ŞEREFNUR ÖZTÜRK →
Flavonoids in Brain Ischemia-Reperfusion and their Effect on Kinases as Signaling Pathway Activity
2025 ISSN: 1871-5273 SCI Q2
Prof. Dr. RASİM MOĞULKOÇ →
Flavonoids in Brain Ischemia-Reperfusion and their Effect on Kinases as Signaling Pathway Activity
2025 ISSN: 1871-5273 SCI-Expanded Q2
Prof. Dr. ABDULKERİM KASIM BALTACI →

Makale Bilgileri

Toplam Atıf 45 atıf · Scopus
ISSN18715273
Yayın TarihiŞubat 2022
Cilt / Sayfa21 · 150-159

Kurumlar

Ankara City Hospital
Ankara Turkey
Hacettepe Üniversitesi
Ankara Turkey
Selçuk Tip Fakültesi
Konya Turkey

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 45.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
CNS and Neurological Disorders - Drug Targets
Q2
SJR Skoru0,789
H-Index105
YayıncıBentham Science Publishers
ÜlkeUnited Arab Emirates
Medicine (miscellaneous) (Q2)
Neuroscience (miscellaneous) (Q2)
Pharmacology (Q2)
Dergi sayfasına git

Metrikler

45
Atıf

Sistemimizdeki Yazarlar